Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.

Autor:	Thrower, S. L.1, James, L.2, Hall, W.2, Green, K. M.3, Arif, S.2, Allen, J. S.2, Van-Krinks, C.2, Lozanoska-Ochser, B.2, Marquesini, L.1, Brown, S.4, Wong, F. S.4, Dayan, C. M.1 colin.dayan@bristol.ac.uk, Peakman, M.1,5
Zdroj:	Clinical & Experimental Immunology. Feb2009, Vol. 155 Issue 2, p156-165. 10p. 2 Diagrams, 5 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu